A Potential Pathogenic Role of Myeloid Derived Suppressor Cells in Autoimmune Arthritis (IRC5P.457)

Chunqing Guo,Fanlei Hu,Zhanguo Li,Xiang-Yang Wang
DOI: https://doi.org/10.4049/jimmunol.192.supp.125.6
2014-01-01
Abstract:Abstract Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of myeloid progenitor cells and immature myeloid cells. Although the role of MDSCs in tumor immune evasion during cancer progression has received much attention, its involvement in other inflammatory autoimmune diseases, such as rheumatoid arthritis (RA) remains largely unknown. We show that the levels of MDSCs are significantly elevated in RA patients and during the progression of collage-induced arthritis (CIA) in mice. While MDSCs in arthritic mice are phenotypically distinct from neutrophils or inflammatory monocytes, they display strong T-cell suppressive activity in vitro, resembling the functionality of tumor expanded MDSCs. Surprisingly, the expansion of MDSCs in lymphoid organs or inflamed joints positively correlate with the disease severity in arthritic mice and RA patients. Additionally, MDSCs from arthritic mice or RA patients efficiently promote the differentiation of naïve CD4+ T cell precursors into T-helper 17 (Th17) cells. Furthermore, pharmacologic elimination or antibody depletion of MDSCs attenuates a Th17 response in arthritic mice, which concomitantly reduces articular cartilage damage and ameliorates the established disease. Our results suggest that an excessive accumulation of MDSCs may exacerbate autoimmune arthritic disease by promoting inflammatory Th17 cells. MDSCs may be exploited as a potential cellular target of intervention in autoimmune arthritis.
What problem does this paper attempt to address?